InvestorsHub Logo
Followers 67
Posts 3213
Boards Moderated 0
Alias Born 06/16/2016

Re: None

Friday, 02/24/2017 12:27:51 AM

Friday, February 24, 2017 12:27:51 AM

Post# of 182908
Breakout Board/most read/active/posted!
USRM-U.S. STEM CELL, INC. "THE LEADER" IN PHASE III
Stem cell therapy for HF is currently being led by the likes of Bioheart (recently renamed US Stem Cell), which has muscle stem cell therapy candidate Myocell in a phase III trial
http://www.pmlive.com/pharma_intelligence/heart_failure_therapy_embarks_on_a_new_era_933222

https://www.cirm.ca.gov/sites/default/files/files/agenda/Fifteen_Cell_Therapies_PhaseIII_Clinical_Trials.pdf

https://clinicaltrials.gov/ct2/show?term=BIOHEART&rank=3

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668534/?report=classic

Promising Results from Company’s MARVEL Trials on MyoCell
The company recently announced positive clinical results for MyoCell following the first part of its Phase II/III, double-blinded, placebo-controlled clinical trial called MARVEL. Over the 6-month observation period in this trial, the most pronounced changes were seen in the cell-treated groups. The six minute walk distance (6MWD), an established parameter of efficacy utilized in heart failure studies, one of the primary end points in the trial, increased on average by more than 91 meters, or 35%, in cell-treated patients, whereas in the placebo-treated group a decrease of nearly 4 meters was seen. This suggests that patients with heart failure could return to a more active lifestyle after receiving Bioheart’s treatment. No stem cell related safety issues such as arrhythmias, or irregular heartbeat, were observed. An arrhythmia event is disturbing but not serious. In the MARVEL trial pre-treatment with amiodarone enabled patients to avoid arrhythmias.

3 YEAR Clinical TRIAL Approaching Completion Date: estimated March 2017
Official Title:
An Open Label, Non-Randomized, Multi-Center Study To Assess The Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intra-Discally in Patients With Degenerative Disc Disease
https://clinicaltrials.gov/show/NCT02097862

A world leader in research and development of stem cell and regenerative medicine treatments for patients with degenerative conditions. Pioneered new applications for diseases and developed more than 30 protocols.
http://us-stemcell.com/en/products/

U.S. STEM CELL, INC. provides accredited training programs in regenerative medicine to physicians throughout the world.
https://www.usstemcelltraining.com/

Stem cell peers 1.00 PPS +!
See for yourself -cc'd from HH (thanks HH):
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128248827&txt2find=regenerative

Check out who Is U.S. STEM CELL, INC. CHIEF SCIENCE OFFICER!!
Kristine Comella designations and @ RAAD conference video:
TOP 50 Stem Cell Scientist in the World!!
https://www.cirm.ca.gov/sites/default/files/files/press_release/Top_50_Global_Stem_Cell_Influencers.pdf

and #1 in Bioleaders!!!
http://www.bioleaders-forum.com/speakers/kristin-comella

Comella @ RAAD!! A MUST WATCH!! Lots of info about the Co. along with testimonials:


U.S. STEM CELL, INC. FACEBOOK PAGE
https://www.facebook.com/USStemCell/?fref=nf

U.S. STEM CELL, INC YOUTUBE CHANNEL
https://www.youtube.com/user/bioheartinc
Did you know US Stem Cell Clinic can treat ED? Buzz ?! :)


U.S. STEM CELL, INC. personal testimonial:


Additional stem cell info.:
https://singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/




- [ ]

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.